Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 117

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Autophagy in Age-Associated Neurodegeneration

Metaxakis, Athanasios, Ploumi, Christina, Tavernarakis, Nektarios · 2018 · Cells

Abstract

The elimination of abnormal and dysfunctional cellular constituents is an essential prerequisite for nerve cells to maintain their homeostasis and proper function. This is mainly achieved through autophagy, a process that eliminates abnormal and dysfunctional cellular components, including misfolded proteins and damaged organelles. Several studies suggest that age-related decline of autophagy impedes neuronal homeostasis and, subsequently, leads to the progression of neurodegenerative disorders due to the accumulation of toxic protein aggregates in neurons. Here, we discuss the involvement of autophagy perturbation in neurodegeneration and present evidence indicating that upregulation of autophagy holds potential for the development of therapeutic interventions towards confronting neurodegenerative diseases in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells7050037

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 149

  1. Yorimitsu, 2005, Autophagy: Molecular machinery for self-eating, Cell Death Differ., 12, 1542, 10.1038/sj.cdd.4401765 · DOI · Paper page
  2. Tsukada, 1993, Isolation and characterization of autophagy-defective mutants of saccharomyces cerevisiae, FEBS Lett., 333, 169, 10.1016/0014-5793(93)80398-E · DOI · Paper page
  3. Harding, 1995, Isolation and characterization of yeast mutants in the cytoplasm to vacuole protein targeting pathway, J. Cell Biol., 131, 591, 10.1083/jcb.131.3.591 · DOI · Paper page
  4. Guan, 2013, Autophagy in stem cells, Autophagy, 9, 830, 10.4161/auto.24132 · DOI · Paper page
  5. Mizushima, 2011, Autophagy: Renovation of cells and tissues, Cell, 147, 728, 10.1016/j.cell.2011.10.026 · DOI · Paper page
  6. Shen, 2014, At the end of the autophagic road: An emerging understanding of lysosomal functions in autophagy, Trends Biochem. Sci., 39, 61, 10.1016/j.tibs.2013.12.001 · DOI · Paper page
  7. Galluzzi, 2016, Amino acid deprivation promotes intestinal homeostasis through autophagy, Oncotarget, 7, 29877, 10.18632/oncotarget.8841 · DOI
  8. Wirawan, 2012, Autophagy: For better or for worse, Cell Res., 22, 43, 10.1038/cr.2011.152 · DOI · Paper page
  9. Lionaki, 2013, Autophagy and ageing: Insights from invertebrate model organisms, Ageing Res. Rev., 12, 413, 10.1016/j.arr.2012.05.001 · DOI · Paper page
  10. Bjedov, 2011, A longer and healthier life with tor down-regulation: Genetics and drugs, Biochem. Soc. Trans., 39, 460, 10.1042/BST0390460 · DOI
  11. Koga, 2011, Chaperone-mediated autophagy dysfunction in the pathogenesis of neurodegeneration, Neurobiol. Dis., 43, 29, 10.1016/j.nbd.2010.07.006 · DOI
  12. Kiriyama, 2015, The function of autophagy in neurodegenerative diseases, Int. J. Mol. Sci., 16, 26797, 10.3390/ijms161125990 · DOI · Paper page
  13. Nakamura, 2018, Autophagy and longevity, Mol. Cells, 41, 65
  14. Yang, 2018, The role of insulin/igf-1/pi3k/akt/gsk3beta signaling in parkinson’s disease dementia, Front. Neurosci., 12, 73, 10.3389/fnins.2018.00073 · DOI · Paper page
  15. Sun, 2018, Suppression of foxo3a attenuates neurobehavioral deficits after traumatic brain injury through inhibiting neuronal autophagy, Behav. Brain Res., 337, 271, 10.1016/j.bbr.2017.08.042 · DOI
  16. Zhang, 2013, Why should autophagic flux be assessed?, Acta Pharmacol. Sin., 34, 595, 10.1038/aps.2012.184 · DOI · Paper page
  17. Button, 2015, Autophagic activity in neuronal cell death, Neurosci. Bull., 31, 382, 10.1007/s12264-015-1528-y · DOI
  18. Lee, 2009, Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional escrt-iii in frontotemporal dementia, J. Neurosci., 29, 8506, 10.1523/JNEUROSCI.0924-09.2009 · DOI
  19. Napolitano, 2016, Tfeb at a glance, J. Cell Sci., 129, 2475, 10.1242/jcs.146365 · DOI · Paper page
  20. Karanasios, 2013, Dynamic association of the ulk1 complex with omegasomes during autophagy induction, J. Cell Sci., 126, 5224
  21. Ganley, 2009, Ulk1.Atg13.Fip200 complex mediates mtor signaling and is essential for autophagy, J. Biol. Chem., 284, 12297, 10.1074/jbc.M900573200 · DOI · Paper page
  22. Russell, 2013, Ulk1 induces autophagy by phosphorylating beclin-1 and activating vps34 lipid kinase, Nat. Cell Biol., 15, 741, 10.1038/ncb2757 · DOI · Paper page
  23. Zhang, 2016, Ampk regulates autophagy by phosphorylating becn1 at threonine 388, Autophagy, 12, 1447, 10.1080/15548627.2016.1185576 · DOI · Paper page
  24. Polson, 2010, Mammalian atg18 (wipi2) localizes to omegasome-anchored phagophores and positively regulates lc3 lipidation, Autophagy, 6, 506, 10.4161/auto.6.4.11863 · DOI · Paper page
  25. Bakula, 2017, Wipi3 and wipi4 beta-propellers are scaffolds for lkb1-ampk-tsc signalling circuits in the control of autophagy, Nat. Commun., 8, 15637, 10.1038/ncomms15637 · DOI · Paper page
  26. Romanov, 2012, Mechanism and functions of membrane binding by the atg5-atg12/atg16 complex during autophagosome formation, EMBO J., 31, 4304, 10.1038/emboj.2012.278 · DOI · Paper page
  27. Ichimura, 2000, A ubiquitin-like system mediates protein lipidation, Nature, 408, 488, 10.1038/35044114 · DOI · Paper page
  28. Zhou, 2017, Regulation of matg9 trafficking by src- and ulk1-mediated phosphorylation in basal and starvation-induced autophagy, Cell Res., 27, 184, 10.1038/cr.2016.146 · DOI · Paper page
  29. Zaffagnini, 2016, Mechanisms of selective autophagy, J. Mol. Biol., 428, 1714, 10.1016/j.jmb.2016.02.004 · DOI · Paper page
  30. Deng, 2017, Autophagy receptors and neurodegenerative diseases, Trends Cell Biol., 27, 491, 10.1016/j.tcb.2017.01.001 · DOI · Paper page
  31. Knorr, 2015, Autophagosome closure requires membrane scission, Autophagy, 11, 2134, 10.1080/15548627.2015.1091552 · DOI
  32. Velikkakath, 2012, Mammalian atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets, Mol. Biol. Cell, 23, 896, 10.1091/mbc.e11-09-0785 · DOI · Paper page
  33. Wang, 2016, Snare-mediated membrane fusion in autophagy, Semin. Cell Dev. Biol., 60, 97, 10.1016/j.semcdb.2016.07.009 · DOI
  34. Reggiori, 2013, Amphisomes: Out of the autophagosome shadow?, EMBO J., 32, 3116, 10.1038/emboj.2013.246 · DOI
  35. Yu, 2012, Dual roles of atg8-pe deconjugation by atg4 in autophagy, Autophagy, 8, 883, 10.4161/auto.19652 · DOI · Paper page
  36. Mauvezin, 2015, Autophagosome-lysosome fusion is independent of v-atpase-mediated acidification, Nat. Commun., 6, 7007, 10.1038/ncomms8007 · DOI · Paper page
  37. Nixon, 2005, Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study, J. Neuropathol. Exp. Neurol., 64, 113, 10.1093/jnen/64.2.113 · DOI · Paper page
  38. Anglade, 1997, Apoptosis and autophagy in nigral neurons of patients with parkinson’s disease, Histol. Histopathol., 12, 25
  39. Boland, 2008, Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer’s disease, J. Neurosci., 28, 6926, 10.1523/JNEUROSCI.0800-08.2008 · DOI · Paper page
  40. Webb, 2004, Microtubule disruption inhibits autophagosome-lysosome fusion: Implications for studying the roles of aggresomes in polyglutamine diseases, Int. J. Biochem. Cell Biol., 36, 2541, 10.1016/j.biocel.2004.02.003 · DOI · Paper page
  41. Nixon, 2005, Endosome function and dysfunction in Alzheimer’s disease and other neurodegenerative diseases, Neurobiol. Aging, 26, 373, 10.1016/j.neurobiolaging.2004.09.018 · DOI · Paper page
  42. Yankner, 2009, Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease, J. Biol. Chem., 284, 4755, 10.1074/jbc.R800018200 · DOI · Paper page
  43. Bloom, 2014, Amyloid-beta and tau: The trigger and bullet in Alzheimer disease pathogenesis, JAMA Neurol., 71, 505, 10.1001/jamaneurol.2013.5847 · DOI
  44. Vassar, 2009, The beta-secretase enzyme bace in health and Alzheimer’s disease: Regulation, cell biology, function, and therapeutic potential, J. Neurosci., 29, 12787, 10.1523/JNEUROSCI.3657-09.2009 · DOI · Paper page
  45. Alonso, 2008, Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies, Curr. Alzheimer Res., 5, 375, 10.2174/156720508785132307 · DOI
  46. Iqbal, 2010, Tau in Alzheimer disease and related tauopathies, Curr. Alzheimer Res., 7, 656, 10.2174/156720510793611592 · DOI · Paper page
  47. Li, 2007, Disruption of microtubule network by alzheimer abnormally hyperphosphorylated tau, Acta Neuropathol., 113, 501, 10.1007/s00401-007-0207-8 · DOI · Paper page
  48. Wolfe, 2013, Autophagy failure in Alzheimer’s disease and the role of defective lysosomal acidification, Eur. J. Neurosci., 37, 1949, 10.1111/ejn.12169 · DOI · Paper page
  49. Nilsson, 2015, Autophagy-related protein 7 deficiency in amyloid beta (abeta) precursor protein transgenic mice decreases abeta in the multivesicular bodies and induces abeta accumulation in the golgi, Am. J. Pathol., 185, 305, 10.1016/j.ajpath.2014.10.011 · DOI
  50. Tammineni, 2017, Impaired retrograde transport of axonal autophagosomes contributes to autophagic stress in Alzheimer’s disease neurons, eLife, 6, e21776, 10.7554/eLife.21776 · DOI · Paper page
  51. Majid, 2014, In vivo axonal transport deficits in a mouse model of fronto-temporal dementia, NeuroImage Clin., 4, 711, 10.1016/j.nicl.2014.02.005 · DOI
  52. Veugelen, 2016, Familial Alzheimer’s disease mutations in presenilin generate amyloidogenic abeta peptide seeds, Neuron, 90, 410, 10.1016/j.neuron.2016.03.010 · DOI
  53. Xia, 2015, Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer’s disease, Neuron, 85, 967, 10.1016/j.neuron.2015.02.010 · DOI · Paper page
  54. Xia, 2016, Loss of abeta43 production caused by presenilin-1 mutations in the knockin mouse brain, Neuron, 90, 417, 10.1016/j.neuron.2016.03.009 · DOI
  55. Ling, D., Song, H.J., Garza, D., Neufeld, T.P., and Salvaterra, P.M. (2009). Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in drosophila. PLoS ONE, 4. · DOI
  56. Pickford, 2008, The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice, J. Clin. Investig., 118, 2190
  57. Jaeger, P.A., Pickford, F., Sun, C.H., Lucin, K.M., Masliah, E., and Wyss-Coray, T. (2010). Regulation of amyloid precursor protein processing by the beclin 1 complex. PLoS ONE, 5. · DOI · Paper page
  58. Rohn, 2011, Depletion of beclin-1 due to proteolytic cleavage by caspases in the Alzheimer’s disease brain, Neurobiol. Dis., 43, 68, 10.1016/j.nbd.2010.11.003 · DOI · Paper page
  59. Omata, 2014, Age-induced reduction of autophagy-related gene expression is associated with onset of Alzheimer’s disease, Am. J. Neurodegener. Dis., 3, 134
  60. Caccamo, 2013, Mtor regulates tau phosphorylation and degradation: Implications for Alzheimer’s disease and other tauopathies, Aging Cell, 12, 370, 10.1111/acel.12057 · DOI · Paper page
  61. Elbaz, 2016, Epidemiology of parkinson’s disease, Rev. Neurol., 172, 14, 10.1016/j.neurol.2015.09.012 · DOI · Paper page
  62. Brichta, 2013, Advances in the pharmacological treatment of parkinson’s disease: Targeting neurotransmitter systems, Trends Neurosci., 36, 543, 10.1016/j.tins.2013.06.003 · DOI · Paper page
  63. Kalia, 2015, Parkinson’s disease, Lancet, 386, 896, 10.1016/S0140-6736(14)61393-3 · DOI · Paper page
  64. Grierson, 2008, Role of axonal transport in neurodegenerative diseases, Annu. Rev. Neurosci., 31, 151, 10.1146/annurev.neuro.31.061307.090711 · DOI · Paper page
  65. Trimmer, 2009, The cybrid model of sporadic parkinson’s disease, Exp. Neurol., 218, 320, 10.1016/j.expneurol.2009.03.016 · DOI
  66. Chu, 2009, Alterations in lysosomal and proteasomal markers in parkinson’s disease: Relationship to alpha-synuclein inclusions, Neurobiol. Dis., 35, 385, 10.1016/j.nbd.2009.05.023 · DOI · Paper page
  67. Whitworth, 2017, Pink1/parkin mitophagy and neurodegeneration-what do we really know in vivo?, Curr. Opin. Genet. Dev., 44, 47, 10.1016/j.gde.2017.01.016 · DOI · Paper page
  68. Valente, 2002, Park6 is a common cause of familial parkinsonism, Neurol. Sci., 23, S117, 10.1007/s100720200097 · DOI
  69. Hardy, 2010, Genetic analysis of pathways to parkinson disease, Neuron, 68, 201, 10.1016/j.neuron.2010.10.014 · DOI · Paper page
  70. Meissner, 2011, The mitochondrial intramembrane protease parl cleaves human pink1 to regulate pink1 trafficking, J. Neurochem., 117, 856, 10.1111/j.1471-4159.2011.07253.x · DOI · Paper page
  71. Yamano, 2013, Pink1 is degraded through the n-end rule pathway, Autophagy, 9, 1758, 10.4161/auto.24633 · DOI · Paper page
  72. Okatsu, 2012, Pink1 autophosphorylation upon membrane potential dissipation is essential for parkin recruitment to damaged mitochondria, Nat. Commun., 3, 1016, 10.1038/ncomms2016 · DOI · Paper page
  73. Koyano, 2014, Ubiquitin is phosphorylated by pink1 to activate parkin, Nature, 510, 162, 10.1038/nature13392 · DOI · Paper page
  74. Wauer, 2015, Mechanism of phospho-ubiquitin-induced parkin activation, Nature, 524, 370, 10.1038/nature14879 · DOI · Paper page
  75. Knuppertz, 2016, Orchestrating the network of molecular pathways affecting aging: Role of nonselective autophagy and mitophagy, Mech. Ageing Dev., 153, 30, 10.1016/j.mad.2016.01.003 · DOI
  76. Ross, 2011, Huntington’s disease: From molecular pathogenesis to clinical treatment, Lancet Neurol., 10, 83, 10.1016/S1474-4422(10)70245-3 · DOI · Paper page
  77. Dayalu, 2015, Huntington disease: Pathogenesis and treatment, Neurol. Clin., 33, 101, 10.1016/j.ncl.2014.09.003 · DOI · Paper page
  78. The huntington’s disease collaborative research group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington’s disease chromosomes. Cell, 72, 971–983. · DOI · Paper page
  79. Saudou, 2016, The biology of huntingtin, Neuron, 89, 910, 10.1016/j.neuron.2016.02.003 · DOI · Paper page
  80. Schwab, 2017, Formation of hippocampal mhtt aggregates leads to impaired spatial memory, hippocampal activation and adult neurogenesis, Neurobiol. Dis., 102, 105, 10.1016/j.nbd.2017.03.005 · DOI
  81. Harjes, 2003, The hunt for huntingtin function: Interaction partners tell many different stories, Trends Biochem. Sci., 28, 425, 10.1016/S0968-0004(03)00168-3 · DOI · Paper page
  82. Steffan, 2010, Does huntingtin play a role in selective macroautophagy?, Cell Cycle, 9, 3401, 10.4161/cc.9.17.12718 · DOI
  83. Dragatsis, 2000, Inactivation of hdh in the brain and testis results in progressive neurodegeneration and sterility in mice, Nat. Genet., 26, 300, 10.1038/81593 · DOI · Paper page
  84. Nasir, 1995, Targeted disruption of the huntington’s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes, Cell, 81, 811, 10.1016/0092-8674(95)90542-1 · DOI · Paper page
  85. Zheng, S., Clabough, E.B., Sarkar, S., Futter, M., Rubinsztein, D.C., and Zeitlin, S.O. (2010). Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet., 6. · DOI · Paper page
  86. Martinez, 2007, On the use of in vivo cargo velocity as a biophysical marker, Biochem. Biophys. Res. Commun., 353, 835, 10.1016/j.bbrc.2006.12.120 · DOI
  87. Rose, 2010, Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of huntington’s disease, Hum. Mol. Genet., 19, 2144, 10.1093/hmg/ddq093 · DOI · Paper page
  88. Tanaka, 2004, Trehalose alleviates polyglutamine-mediated pathology in a mouse model of huntington disease, Nat. Med., 10, 148, 10.1038/nm985 · DOI · Paper page
  89. Tsunemi, 2012, Pgc-1alpha rescues huntington’s disease proteotoxicity by preventing oxidative stress and promoting tfeb function, Sci. Transl. Med., 4, 142ra197, 10.1126/scitranslmed.3003799 · DOI · Paper page
  90. Niccoli, 2017, Ageing as a risk factor for als/ftd, Hum. Mol. Genet., 26, R105, 10.1093/hmg/ddx247 · DOI
  91. Siddique, 2015, Sporadic and hereditary amyotrophic lateral sclerosis (als), Biochim. Biophys. Acta, 1852, 679, 10.1016/j.bbadis.2014.08.010 · DOI · Paper page
  92. Wang, Q., Johnson, J.L., Agar, N.Y., and Agar, J.N. (2008). Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol., 6. · DOI · Paper page
  93. Blokhuis, 2013, Protein aggregation in amyotrophic lateral sclerosis, Acta Neuropathol., 125, 777, 10.1007/s00401-013-1125-6 · DOI · Paper page
  94. Tian, 2011, In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis, Autophagy, 7, 985, 10.4161/auto.7.9.16012 · DOI
  95. Chen, 2012, Autophagy dysregulation in amyotrophic lateral sclerosis, Brain Pathol., 22, 110, 10.1111/j.1750-3639.2011.00546.x · DOI · Paper page
  96. Deng, 2017, Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?, Mol. Neurodegener., 12, 90, 10.1186/s13024-017-0232-6 · DOI
  97. Chen, 2015, The altered autophagy mediated by tfeb in animal and cell models of amyotrophic lateral sclerosis, Am. J. Transl. Res., 7, 1574
  98. Mori, 2013, The c9orf72 ggggcc repeat is translated into aggregating dipeptide-repeat proteins in ftld/als, Science, 339, 1335, 10.1126/science.1232927 · DOI · Paper page
  99. Corbier, 2017, C9orf72 is a gdp/gtp exchange factor for rab8 and rab39 and regulates autophagy, Small GTPases, 8, 181, 10.1080/21541248.2016.1212688 · DOI
  100. Webster, C.P., Smith, E.F., Grierson, A.J., and De Vos, K.J. (2016). C9orf72 plays a central role in rab gtpase-dependent regulation of autophagy. Small GTPases, 1–10. · DOI
  101. Goode, 2016, Defective recognition of lc3b by mutant sqstm1/p62 implicates impairment of autophagy as a pathogenic mechanism in als-ftld, Autophagy, 12, 1094, 10.1080/15548627.2016.1170257 · DOI · Paper page
  102. Shen, 2015, Mutations in the ubiquitin-binding domain of optn/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism, Autophagy, 11, 685, 10.4161/auto.36098 · DOI · Paper page
  103. Wong, 2015, Temporal dynamics of park2/parkin and optn/optineurin recruitment during the mitophagy of damaged mitochondria, Autophagy, 11, 422, 10.1080/15548627.2015.1009792 · DOI
  104. Moore, 2016, Dynamic recruitment and activation of als-associated tbk1 with its target optineurin are required for efficient mitophagy, Proc. Natl. Acad. Sci. USA, 113, E3349, 10.1073/pnas.1523810113 · DOI · Paper page
  105. Hafezparast, 2003, Mutations in dynein link motor neuron degeneration to defects in retrograde transport, Science, 300, 808, 10.1126/science.1083129 · DOI · Paper page
  106. Ilieva, 2008, Mutant dynein (loa) triggers proprioceptive axon loss that extends survival only in the sod1 als model with highest motor neuron death, Proc. Natl. Acad. Sci. USA, 105, 12599, 10.1073/pnas.0805422105 · DOI
  107. Puls, 2003, Mutant dynactin in motor neuron disease, Nat. Genet., 33, 455, 10.1038/ng1123 · DOI · Paper page
  108. LaMonte, 2002, Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration, Neuron, 34, 715, 10.1016/S0896-6273(02)00696-7 · DOI · Paper page
  109. Vilmont, 2016, Dynein disruption perturbs post-synaptic components and contributes to impaired musk clustering at the nmj: Implication in als, Sci. Rep., 6, 27804, 10.1038/srep27804 · DOI
  110. Zhang, 2007, Interaction between familial amyotrophic lateral sclerosis (als)-linked sod1 mutants and the dynein complex, J. Biol. Chem., 282, 16691, 10.1074/jbc.M609743200 · DOI · Paper page
  111. Gamerdinger, 2011, Bag3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins, EMBO Rep., 12, 149, 10.1038/embor.2010.203 · DOI · Paper page
  112. Carra, 2008, Hspb8 chaperone activity toward poly(q)-containing proteins depends on its association with bag3, a stimulator of macroautophagy, J. Biol. Chem., 283, 1437, 10.1074/jbc.M706304200 · DOI · Paper page
  113. Sturner, 2017, The role of the multifunctional bag3 protein in cellular protein quality control and in disease, Front. Mol. Neurosci., 10, 177, 10.3389/fnmol.2017.00177 · DOI · Paper page
  114. Diot, 2015, A novel quantitative assay of mitophagy: Combining high content fluorescence microscopy and mitochondrial DNA load to quantify mitophagy and identify novel pharmacological tools against pathogenic heteroplasmic mtdna, Pharmacol. Res., 100, 24, 10.1016/j.phrs.2015.07.014 · DOI
  115. Diot, 2016, Mitophagy plays a central role in mitochondrial ageing, Mamm. Genome, 27, 381, 10.1007/s00335-016-9651-x · DOI
  116. Onyango, 2010, Regulation of neuron mitochondrial biogenesis and relevance to brain health, Biochim. Biophys. Acta, 1802, 228, 10.1016/j.bbadis.2009.07.014 · DOI · Paper page
  117. Wenz, 2011, Mitochondria and pgc-1alpha in aging and age-associated diseases, J. Aging Res., 2011, 810619, 10.4061/2011/810619 · DOI
  118. Picca, 2013, Age- and calorie restriction-related changes in rat brain mitochondrial DNA and tfam binding, Age, 35, 1607, 10.1007/s11357-012-9465-z · DOI
  119. Grimm, 2017, Brain aging and neurodegeneration: From a mitochondrial point of view, J. Neurochem., 143, 418, 10.1111/jnc.14037 · DOI · Paper page
  120. Matecic, M., Smith, D.L., Pan, X., Maqani, N., Bekiranov, S., Boeke, J.D., and Smith, J.S. (2010). A microarray-based genetic screen for yeast chronological aging factors. PLoS Genet., 6. · DOI · Paper page
  121. Bjedov, 2010, Mechanisms of life span extension by rapamycin in the fruit fly drosophila melanogaster, Cell Metabol., 11, 35, 10.1016/j.cmet.2009.11.010 · DOI · Paper page
  122. Morselli, 2011, Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome, J. Cell Biol., 192, 615, 10.1083/jcb.201008167 · DOI · Paper page
  123. Choi, 2013, Resveratrol induces autophagy through death-associated protein kinase 1 (dapk1) in human dermal fibroblasts under normal culture conditions, Exp. Dermatol., 22, 491, 10.1111/exd.12175 · DOI
  124. Park, 2016, Yes-associated protein 1 and transcriptional coactivator with pdz-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma, Hepatology, 63, 159, 10.1002/hep.28223 · DOI
  125. Berger, 2006, Rapamycin alleviates toxicity of different aggregate-prone proteins, Hum. Mol. Genet., 15, 433, 10.1093/hmg/ddi458 · DOI · Paper page
  126. Moors, 2017, Therapeutic potential of autophagy-enhancing agents in parkinson’s disease, Mol. Neurodegener., 12, 11, 10.1186/s13024-017-0154-3 · DOI · Paper page
  127. Martin, 2015, Autophagy in huntington disease and huntingtin in autophagy, Trends Neurosci., 38, 26, 10.1016/j.tins.2014.09.003 · DOI · Paper page
  128. Majumder, S., Richardson, A., Strong, R., and Oddo, S. (2011). Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS ONE, 6. · DOI · Paper page
  129. Liang, 2014, Dysfunctional autophagy in Alzheimer’s disease: Pathogenic roles and therapeutic implications, Neurosci. Bull., 30, 308, 10.1007/s12264-013-1418-8 · DOI
  130. Li, 2013, Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-beta pathology in a mouse model of Alzheimer’s disease, Curr. Alzheimer Res., 10, 433, 10.2174/1567205011310040008 · DOI
  131. Jiang, 2014, Temsirolimus promotes autophagic clearance of amyloid-beta and provides protective effects in cellular and animal models of Alzheimer’s disease, Pharmacol. Res., 81, 54, 10.1016/j.phrs.2014.02.008 · DOI · Paper page
  132. Chu, C., Zhang, X., Ma, W., Li, L., Wang, W., Shang, L., and Fu, P. (2013). Induction of autophagy by a novel small molecule improves abeta pathology and ameliorates cognitive deficits. PLoS ONE, 8. · DOI
  133. Tian, 2011, A small-molecule enhancer of autophagy decreases levels of abeta and app-ctf via atg5-dependent autophagy pathway, FASEB J., 25, 1934, 10.1096/fj.10-175158 · DOI · Paper page
  134. Jin, 2008, Neuroprotective effect of resveratrol on 6-ohda-induced parkinson’s disease in rats, Eur. J. Pharmacol., 600, 78, 10.1016/j.ejphar.2008.10.005 · DOI · Paper page
  135. Vidoni, C., Secomandi, E., Castiglioni, A., Melone, M.A.B., and Isidoro, C. (2017). Resveratrol protects neuronal-like cells expressing mutant huntingtin from dopamine toxicity by rescuing atg4-mediated autophagosome formation. Neurochem. Int. · DOI
  136. Hebron, 2013, Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of alpha-synuclein in parkinson’s disease models, Hum. Mol. Genet., 22, 3315, 10.1093/hmg/ddt192 · DOI · Paper page
  137. Yu, 2013, Nilotinib induces autophagy in hepatocellular carcinoma through ampk activation, J. Biol. Chem., 288, 18249, 10.1074/jbc.M112.446385 · DOI
  138. Song, 2016, Mechanism of metformin: A tale of two sites, Diabetes Care, 39, 187, 10.2337/dci15-0013 · DOI · Paper page
  139. Ma, 2007, Metformin therapy in a transgenic mouse model of huntington’s disease, Neurosci. Lett., 411, 98, 10.1016/j.neulet.2006.10.039 · DOI · Paper page
  140. Haghani, 2015, The therapeutic potential of berberine against the altered intrinsic properties of the ca1 neurons induced by abeta neurotoxicity, Eur. J. Pharmacol., 758, 82, 10.1016/j.ejphar.2015.03.016 · DOI
  141. Kim, 2014, Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with parkinson’s disease, Int. J. Mol. Med., 33, 870, 10.3892/ijmm.2014.1656 · DOI
  142. Jiang, W., Wei, W., Gaertig, M.A., Li, S., and Li, X.J. (2015). Therapeutic effect of berberine on huntington’s disease transgenic mouse model. PLoS ONE, 10. · DOI
  143. Yu, 2014, Berberine-induced apoptotic and autophagic death of hepg2 cells requires ampk activation, Cancer Cell Int., 14, 49, 10.1186/1475-2867-14-49 · DOI
  144. Rodriguez, 2010, Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation, Neurobiol. Dis., 39, 423, 10.1016/j.nbd.2010.05.014 · DOI · Paper page
  145. Castillo, 2013, Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons, Autophagy, 9, 1308, 10.4161/auto.25188 · DOI · Paper page
  146. Feng, 2008, Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model, Neuroscience, 155, 567, 10.1016/j.neuroscience.2008.06.040 · DOI · Paper page
  147. Zhang, 2011, Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer’s disease transgenic mouse model, J. Alzheimers Dis., 24, 739, 10.3233/JAD-2011-101875 · DOI
  148. Pizzasegola, 2009, Treatment with lithium carbonate does not improve disease progression in two different strains of sod1 mutant mice, Amyotroph. Lateral Scler., 10, 221, 10.1080/17482960902803440 · DOI
  149. Sade, 2016, Ip3 accumulation and/or inositol depletion: Two downstream lithium’s effects that may mediate its behavioral and cellular changes, Transl. Psychiatry, 6, e968, 10.1038/tp.2016.217 · DOI

Cited by

See all 117

Metadata

Authors
Metaxakis, A., Ploumi, C., & Tavernarakis, N.
Affiliations
Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, Heraklion 70013, Crete, Greece
Venue
Cells
Publisher
MDPI AG
Published
2018-05-05
Volume
7
Issue
5
Pages
37
ISSN
2073-4409
Cited by
117
References
85
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.